Trademarkia Logo

Canada

C$
Trademark Search in Canada
ARCH Design

View On IC.GC.CA

ARCH Design
ABANDONED SECTION 36

on 29 Dec 2021

Last Applicant/ Owned by

Intarcia Therapeutics, Inc.

One Marina Park Drive, Suite 1300Boston, Massachusetts 02210

US

Serial Number

1816222 filed on 29th Dec 2016

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

ARCH Design

Trademark usage description

pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, obesity and dyslipidemia, filled in drug delivery Read More

Vienna Information

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 2

Surfaces or backgrounds covered with lozenge shapesSurfaces ou fonds couverts de losanges

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 5

One quadrilateralUn quadrilatère

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, obesity and dyslipidemia, filled in drug delivery devices, namely implantable mini-pump drug delivery systems; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, obesity and dyslipidemia; diagnostic preparations and reagents for clinical or medical laboratory use, all for in vivo use; surgical preparation supplies, namely, swabs, anesthetic preparations, alcohol prep pads, skin adhesive, bandages, wound closure strips, and gauze

Classification kind code

11

Class [010]
Drug delivery systems and devices, namely, implantable osmotic mini-pumps and parts and fittings therefor; implantable osmotic mini-pump drug delivery systems for the continuous release of a therapeutic formulation for the treatment of diabetes and parts and fittings therefor; medical apparatus for the administration of pharmaceuticals, biopharmaceuticals, vaccines and other therapeutic formulations in the nature of an implantable pump and parts and fittings therefor; medical apparatus for the administration of pharmaceuticals, biopharmaceuticals, vaccines and other therapeutic formulations in the nature of an implantable pump and parts and fittings therefor; medical apparatus and instruments for implanting and removing subdermal drug delivery devices in the nature of surgical preparation instruments and supplies, namely trays, needles, gloves, syringe, scalpel, placement tool, hemostat, and removal tool and parts and fittings therefor; medical apparatus for treatment of diabetes, obesity and metabolic diseases and disorders in the nature of an implantable pump filled with pharmaceutical preparations and parts and fittings therefor; medical apparatus for treatment of diabetes, obesity and metabolic diseases and disorders, namely, malfunctioning condition of the body's metabolism process, in the nature of an implantable pump and parts and fittings therefor

Classification kind code

11

Class [042]
Providing scientific, pharmaceutical and medical research and development services in the fields of diabetes, obesity, metabolic diseases and disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; design and testing services in the fields of pharmaceuticals, biopharmaceuticals, science, namely, pharmacology and biochemistry, medicine and drug delivery systems; research and development of new clinical products, drugs, pharmaceuticals and drug delivery systems and devices; computational and experimental research and development activities directed towards the identification and optimal formulation of compounds into stabilized pharmaceutical preparations that can be delivered via implantable pumps; computational and experimental research and development activities directed towards the development of drugs and drug delivery systems; information and advisory services in the field of pharmaceuticals, pharmacology and biochemistry, medicine; Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases and disorders, namely, malfunctioning condition of the body's metabolism process, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of diabetes, obesity, metabolic diseases and disorders, namely, malfunctioning condition of the body's metabolism process, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases and disorders, namely, malfunctioning condition of the body's metabolism process, drug delivery technologies, and administration of pharmaceuticals

Classification kind code

11

Class [044]
Drug delivery technologies, namely, the provision of information in the field of pharmaceuticals, pharmacology and biochemistry and drug delivery technologies on-line from a computer network and via the Internet and extranets

Classification kind code

11

Mark Details

Serial Number

1816222

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 12
on 22nd Oct 2019		Extension of Time
Submitted for opposition 67
on 11th Sept 2019		Agent Name Changed
Submitted for opposition 15
on 15th Apr 2019		Correspondence Created
Submitted for opposition 15
on 11th Jun 2018		Correspondence Created
Submitted for opposition 135
on 19th Jan 2018		Amendment to Application
Submitted for opposition 22
on 1st Dec 2017		Search Recorded
Submitted for opposition 20
on 1st Dec 2017		Examiner's First Report
Submitted for opposition 31
on 4th Jan 2017		Formalized
Submitted for opposition 30
on 29th Dec 2016		Filed
Submitted for opposition 1
on 29th Dec 2016		Created